Paper17877427
Characterization of the theorectical radiation dose enhancement from nanoparticles.
Roeske JC and 4 others. Technol Cancer Res Treat, 2007. Cited by 102 papers, by iCite.
Cite this record
ConductScience Library. Characterization of the theorectical radiation dose enhancement from nanoparticles. Papers, record 17877427. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17877427
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nanoparticles | Major topic |
| Neoplasms | Major topic |
| Radiation Dosage | Major topic |
| Radioisotopes | Major topic |
| Animals | |
| Brachytherapy | |
| Dose-Response Relationship, Radiation | |
| Humans | |
| Models, Theoretical | |
| Radiotherapy Dosage |
Source PubMed
Cited by56
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 102 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794870 | The Impact of Nanoparticles on Proton Therapy: A Review Study. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42794870 | PubMed |
| 41899847 | Simulation-Based X-Ray Spectrum Optimization for Dose Enhancement in X-Ray-Induced Photodynamic Therapy with NaLuF4:20% Gd, 15% Tb3+ Nanocrystals. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/41899847 | PubMed |
| 41684504 | Dose Enhancement Due to Various Nanoparticles Irradiated by Megavoltage Photon Beams: A Review Study. | J Med Phys | 2025 | https://conductscience.org/library/papers/41684504 | PubMed |
| 41304042 | Poly(glycerol)-Functionalized Gadolinium Tungstate Nanoflakes Loaded with Chlorin e6: Photodynamic Efficacy and Radiosensitization Potential for Multimodal Cancer Therapy. | Materials (Basel) | 2025 | https://conductscience.org/library/papers/41304042 | PubMed |
| 40959486 | Combined physical and biological contributions to radiotherapy enhancement by Lu-based nanoscintillators in pancreatic cancer models. | Nanotheranostics | 2025 | https://conductscience.org/library/papers/40959486 | PubMed |
| 40213580 | Nanoscintillator Coating: A Key Parameter That Strongly Impacts Internalization, Biocompatibility, and Therapeutic Efficacy in Pancreatic Cancer Models. | Small Sci | 2024 | https://conductscience.org/library/papers/40213580 | PubMed |
| 38935922 | Nanoscale gold nanoparticle (GNP)-laden tumor cell model and its use for estimation of intracellular dose from GNP-induced secondary electrons. | Med Phys | 2024 | https://conductscience.org/library/papers/38935922 | PubMed |
| 38703297 | Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape. | EJNMMI Radiopharm Chem | 2024 | https://conductscience.org/library/papers/38703297 | PubMed |
| 38449099 | The Effect of Dose Enhancement in Tumor With Silver Nanoparticles on Surrounding Healthy Tissues: A Monte Carlo Study. | Technol Cancer Res Treat | 2024 | https://conductscience.org/library/papers/38449099 | PubMed |
| 38063741 | Monitoring Tools and Strategies for Effective Electrokinetic Nanoparticle Treatment. | Nanomaterials (Basel) | 2023 | https://conductscience.org/library/papers/38063741 | PubMed |
| 37947718 | Inorganic Nanoparticles as Radiosensitizers for Cancer Treatment. | Nanomaterials (Basel) | 2023 | https://conductscience.org/library/papers/37947718 | PubMed |
| 37555747 | Prospects of nanoparticle-based radioenhancement for radiotherapy. | Mater Horiz | 2023 | https://conductscience.org/library/papers/37555747 | PubMed |
| 37374815 | Depth Dose Enhancement in Orthovoltage Nanoparticle-Enhanced Radiotherapy: A Monte Carlo Phantom Study. | Micromachines (Basel) | 2023 | https://conductscience.org/library/papers/37374815 | PubMed |
| 36980778 | The Promise of Nanoparticles-Based Radiotherapy in Cancer Treatment. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36980778 | PubMed |
| 36873996 | Nanoparticle-based radiosensitization strategies for improving radiation therapy. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36873996 | PubMed |
| 36081572 | Natural Baicalein-Rich Fraction as Radiosensitizer in Combination with Bismuth Oxide Nanoparticles and Cisplatin for Clinical Radiotherapy. | Int J Nanomedicine | 2022 | https://conductscience.org/library/papers/36081572 | PubMed |
| 35668122 | Catalytic activity imperative for nanoparticle dose enhancement in photon and proton therapy. | Nat Commun | 2022 | https://conductscience.org/library/papers/35668122 | PubMed |
| 35454910 | Deep-Tissue Activation of Photonanomedicines: An Update and Clinical Perspectives. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35454910 | PubMed |
| 35261497 | Use of Poly (Ethylene Glycol) Coated Superparamagnetic Iron Oxide Nanoparticles as Radio Sensitizer in Enhancing Colorectal Cancer Radiation Efficacy. | J Med Phys | 2021 | https://conductscience.org/library/papers/35261497 | PubMed |
| 35053455 | ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35053455 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17877427
GET https://conductscience.org/api/papers/v1/17877427/cited_by?page=2